Keywords: cancer immunotherapy, prostate cancer, bladder cancer, kidney cancer
The Miller lab is interested in understanding how tumors evade the immune response and how we can better activate the immune system to fight cancer. We have a particular focus on a type of immune cell, myeloid cells, that can regulate many aspects of the immune response and are not targeted by current immunotherapies. Using single-cell and functional genomics approaches, we hope to identify novel myeloid-directed therapies that allow us to overcome resistance and successfully treat more patients.
Training Program Affiliations:
- Genetics and Molecular Biology